(19)
(11) EP 1 158 979 A2

(12)

(88) Date of publication A3:
11.01.2001

(43) Date of publication:
05.12.2001 Bulletin 2001/49

(21) Application number: 00912529.5

(22) Date of filing: 02.03.2000
(51) International Patent Classification (IPC)7A61K 31/445, A61K 9/06, A61K 47/02
(86) International application number:
PCT/EP0001/726
(87) International publication number:
WO 0051/603 (08.09.2000 Gazette 2000/36)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 04.03.1999 GB 9904931

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • Galante, Leonard John
    Research Triangle Park, NC 27709 (US)
  • Heiman, Shirley Ann
    Research Triangle Park, NC 27709 (US)
  • Igo, David H.
    Research Triangle Park, NC 27709 (US)
  • Nguyen, Ngoc-Anh Thi
    Research Triangle Park, NC 27709 (US)

(74) Representative: Reeves, Julie Frances et al
GlaxoSmithKline,Two New Horizons Court
Brentford,Middlesex TW8 9EP
Brentford,Middlesex TW8 9EP (GB)

   


(54) COMPOSITIONS OF REMIFENTANIL